Next Article in Journal
Are ENT1/ENT1, NOTCH3, and miR-21 Reliable Prognostic Biomarkers in Patients with Resected Pancreatic Adenocarcinoma Treated with Adjuvant Gemcitabine Monotherapy?
Next Article in Special Issue
Cachectic Body Composition and Inflammatory Markers Portend a Poor Prognosis in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiation
Previous Article in Journal
A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
Previous Article in Special Issue
Plasma Metabolomics Identifies Lipid and Amino Acid Markers of Weight Loss in Patients with Upper Gastrointestinal Cancer
 
 
Perspective

Article Versions Notes

Cancers 2019, 11(11), 1619; https://doi.org/10.3390/cancers11111619
Action Date Notes Link
article xml file uploaded 23 October 2019 10:26 CEST Original file -
article xml uploaded. 23 October 2019 10:26 CEST Update https://www.mdpi.com/2072-6694/11/11/1619/xml
article pdf uploaded. 23 October 2019 10:26 CEST Version of Record https://www.mdpi.com/2072-6694/11/11/1619/pdf
article html file updated 23 October 2019 10:32 CEST Original file -
article html file updated 29 November 2019 01:18 CET Update -
article html file updated 29 November 2019 07:55 CET Update -
article html file updated 14 February 2020 03:06 CET Update -
article html file updated 20 July 2022 01:07 CEST Update https://www.mdpi.com/2072-6694/11/11/1619/html
Back to TopTop